title: Dose-Finding Trials: Optimizing Phase 2 Data in the Drug Development Process.
authors.affiliation: Berry Consultants LLC, Austin, Texas.
authors.forename: Kert
authors.initials: K
authors.lastname: Viele
authors.affiliation: Berry Consultants LLC, Austin, Texas2University of Central Florida College of Medicine, Orlando.
authors.forename: Jason T
authors.initials: JT
authors.lastname: Connor
mesh_terms: D005260:Female; D006162:Guanylate Cyclase / Q000187:drug effects*; D006333:Heart Failure / Q000188:drug therapy*; D006574:Heterocyclic Compounds, 2-Ring / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011743:Pyrimidines / Q000627:therapeutic use*; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy*
chemical_list: D006574:Heterocyclic Compounds, 2-Ring; D011743:Pyrimidines; D006162:Guanylate Cyclase